Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis

Chapter 2 Executive Summary
2.1 Market Snapshot

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing prevalence of target diseases
3.1.1.2 Preference to minimally invasive procedures
3.1.2 Market restraint analysis
3.1.2.1 Lack of level 1 evidence for atherectomy
3.1.2.2 Lack of technical training for the procedure
3.1.2.3 Significant adoption of alternative therapies
3.2 Penetration & Growth Prospects Mapping
3.3 U.S. Atherectomy Devices Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s
3.5 U.S. Atherectomy Devices: Regulatory Scenario
3.6 U.S. Atherectomy Devices Market: Reimbursement Scenario
3.7 Key Clinical Trials & Studies
3.7.1 Opinions/Views on Key Clinical Trials and Their Impact on the Market and Customer
3.8 U.S. Peripheral Atherectomy: Number of Procedures

Chapter 4 U.S. Atherectomy Devices Market: Type Estimates & Trend Analysis
4.1 U.S. Atherectomy Devices Market: Type Movement Analysis
4.2 Directional Atherectomy Devices
4.2.1 Directional atherectomy devices market, 2014 - 2025 (USD Million)
4.3 Rotational Atherectomy Devices
4.3.1 Rotational atherectomy market, 2014 - 2025 (USD Million)
4.4 Orbital Atherectomy Devices
4.4.1 Orbital atherectomy devices market, 2014 - 2025 (USD Million)
4.5 Laser Atherectomy Devices
4.5.1 Laser atherectomy devices market, 2014 - 2025 (USD Million)

Chapter 5 U.S. Atherectomy Devices Market: End Use Estimates & Trend Analysis
5.1 U.S. Atherectomy Devices Market: End Use Movement Analysis
5.2 In-Patient Facility
5.2.1 In-patient facility market, 2014 - 2025 (USD Million)
5.3 Office-Based Labs (OBLs)
5.3.1 Office-based labs (OBLs) market, 2014 - 2025 (USD Million)
5.4 Out-Patient facility
5.4.1 Out-patient facility, 2014 - 2025 (USD Million)

Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Competitive Landscape: Market Position Analysis
6.3 Company Profiles
6.3.1 Boston Scientific Corporation
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 SWOT analysis
6.3.1.4 Product benchmarking
6.3.1.5 Strategic initiatives
6.3.2 Cardiovascular Systems, Inc.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 SWOT analysis
6.3.2.4 Product benchmarking
6.3.2.5 Strategic initiatives
6.3.3 Medtronic
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 SWOT analysis
6.3.3.4 Product benchmarking
6.3.3.5 Strategic initiatives
6.3.4 Spectranetics
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 SWOT analysis
6.3.4.4 Product benchmarking
6.3.4.5 Strategic initiatives
6.3.5 Avinger
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 ST. JUDE MEDICAL
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 SWOT analysis
6.3.6.4 Product benchmarking
6.3.7 Cardinal Health (Cordis)
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 SWOT analysis
6.3.7.4 Product benchmarking
6.3.7.5 Strategic initiatives
6.3.8 Terumo Medical Corporation
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 SWOT analysis
6.3.8.4 Product benchmarking
6.3.8.5 Strategic initiatives

Chapter 7 Recommendations
7.1 KOL Views
7.2 Recommendations

List of Tables
TABLE 1 Atherectomy devices comparison
TABLE 2 Comparison of cutting balloon angioplasty vs rotational atherectomy
TABLE 3 Procedure codes and physician reimbursement for endovascular procedures, 2018
TABLE 4 Ambulatory surgery center reimbursement for endovascular procedures, 2018
TABLE 5 Medicare national average payments, 2017
TABLE 6 Medicare reimbursement by clinical setting, 2016
TABLE 7 Medicare reimbursement comparison, 2014
TABLE 8 Patient selection criteria
TABLE 9 Patient selection criteria
TABLE 10 Patient selection criteria
TABLE 11 List of in-patient facility performing atherectomy in the U.S.
TABLE 12 Top five states performing endovascular procedures including atherectomy in OBLs, 2016

List of Figures
FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market summary 2018 (USD Million)
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Prevalence of PAD (%) by age group (years), 2016
FIG. 12 Market restraint relevance analysis (Current &future impact)
FIG. 13 Penetration & growth prospect mapping
FIG. 14 U.S. atherectomy devices market - PESTLE analysis
FIG. 15 Porter’s Five Forces Analysis
FIG. 16 U.S. atherectomy devices market type outlook key takeaways
FIG. 17 U.S. atherectomy devices: Type movement analysis
FIG. 18 Directional atherectomy devices market, 2014 - 2025 (USD Million)
FIG. 19 Above knee atherosclerosis
FIG. 20 Below knee atherosclerosis
FIG. 21 Rotational atherectomy market, 2014 - 2025 (USD Million)
FIG. 22 Orbital atherectomy devices market, 2014 - 2025 (USD Million)
FIG. 23 Laser atherectomy devices market, 2014 - 2025 (USD Million)
FIG. 24 U.S. atherectomy devices market end-use outlook key takeaways
FIG. 25 U.S. atherectomy devices: End-use movement analysis
FIG. 26 In-patient facility market, 2014 - 2025 (USD Million)
FIG. 27 Office-based labs (OBLs) market, 2014 - 2025 (USD Million)
FIG. 28 Out-patient facility market, 2014 - 2025 (USD Million)
FIG. 29 Strategy framework
FIG. 30 U.S. atherectomy devices market: Heat map analysis

Companies profiled:

Boston Scientific Corporation
Cardiovascular Systems, Inc.
Medtronic
Spectranetics
Avinger
ST. JUDE MEDICAL
Cardinal Health (Cordis)
Terumo Medical Corporation